M Blaese - JoVE Visualize

Showing results (101-110 of 171) with videos related to

Pageof 18

Sort By:

Journal of the National Cancer Institute|June 1, 1977

Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosisN A Sher, D G Poplack, R M Blaese, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 9, 1995

Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease geneS P Kwan, T L Hagemann, B E Radtke, et al.

Human Gene Therapy|July 1, 1997

A simple and reliable method for screening retroviral producer clones without selectable markersM Onodera, A Yachie, D M Nelson, et al.

Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1975

Malignant lymphoma of the jejunum in a patient with Wiskott-Aldrich syndrome. Surgical treatmentR P Faraci, H J Hoffstrand, F G Witebsky, et al.

Gene Therapy|May 26, 1999

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancerO Wildner, J C Morris, N N Vahanian, et al.

Annals of Internal Medicine|May 1, 1976

Familial chronic lymphocytic leukemia. Immunologic and cellular characterizationW A Blattner, W Strober, A V Muchmore, et al.

Gene Therapy|November 3, 1998

Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expressionO Wildner, F Candotti, E G Krecko, et al.

Blood|April 15, 1996

Retroviral-mediated gene correction for X-linked severe combined immunodeficiencyF Candotti, J A Johnston, J M Puck, et al.

Journal of Neurosurgery|September 1, 1993

Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumorsZ Ram, K W Culver, S Walbridge, et al.

Cancer Gene Therapy|November 1, 2001

Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virusR Yamanaka, S A Zullo, J Ramsey, et al.

Pageof 18

Showing results (101-110 of 171) with videos related to

Sort By:

Pageof 18

Journal of the National Cancer Institute|June 1, 1977

Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosisN A Sher, D G Poplack, R M Blaese, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 9, 1995

Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease geneS P Kwan, T L Hagemann, B E Radtke, et al.

Human Gene Therapy|July 1, 1997

A simple and reliable method for screening retroviral producer clones without selectable markersM Onodera, A Yachie, D M Nelson, et al.

Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1975

Malignant lymphoma of the jejunum in a patient with Wiskott-Aldrich syndrome. Surgical treatmentR P Faraci, H J Hoffstrand, F G Witebsky, et al.

Gene Therapy|May 26, 1999

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancerO Wildner, J C Morris, N N Vahanian, et al.

Annals of Internal Medicine|May 1, 1976

Familial chronic lymphocytic leukemia. Immunologic and cellular characterizationW A Blattner, W Strober, A V Muchmore, et al.

Gene Therapy|November 3, 1998

Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expressionO Wildner, F Candotti, E G Krecko, et al.

Blood|April 15, 1996

Retroviral-mediated gene correction for X-linked severe combined immunodeficiencyF Candotti, J A Johnston, J M Puck, et al.

Journal of Neurosurgery|September 1, 1993

Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumorsZ Ram, K W Culver, S Walbridge, et al.

Cancer Gene Therapy|November 1, 2001

Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virusR Yamanaka, S A Zullo, J Ramsey, et al.

Pageof 18